- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Finarenone is a new type of non steroidal mineralocorticoid receptor antagonist, which is mainly used to treat type 2 diabetes related chronic ...
Finerenone is a non steroidal mineralocorticoid receptor antagonist used to treat chronic kidney disease and type 2 diabetes. The following wil...
The contraindications for lorlatinib mainly include patients with severe liver and kidney dysfunction and pregnant women, and special attention...
Loratinib may cause side effects such as edema, peripheral neuropathy, and cognitive impairment, and requires targeted management. Edema can be...
The use of lorlatinib should focus on central nervous system side effects, hyperlipidemia, and the risk of weight gain. The impact on the centr...
Boratinib is a targeted drug used to treat non-small cell lung cancer. Its standard dose is 100mg orally per day, and the dose needs to be adju...
During the treatment of Capivasertib, it is important to focus on managing common side effects such as nausea, rash, and stomatitis. Symptoms c...
The contraindicated population of Capasertib mainly includes special populations such as patients with type 1 diabetes and patients with severe...
During the treatment of Capivasertib, special attention should be paid to adverse reactions such as high blood sugar, diarrhea, and skin toxici...
Capasertib is an AKT inhibitor, which is currently mainly used to treat hormone receptor positive (HR+) and HER2 negative (HER2-) advanced brea...
